Human Cytomegalovirus Infection in Haematopoietic Stem Cell Transplant Recipients and CAR T Cell Recipients - PART 1: Risk Factors, Clinical Impact and Immune Response. (PubMed, Rev Med Virol) - Apr 15, 2026 - "Continued viral surveillance and investigation of viral dynamics with correlative studies of immune function are needed in this patient population. Current and emerging strategies for treatment and prevention of HCMV complications in allo-HSCT, including use of letermovir prophylaxis and adoptive HCMV-specific T cell therapies, are explored in the following article (Part 2)."
Journal • Review • Bone Marrow Transplantation • Cytomegalovirus Infection • Graft versus Host Disease • Immunology • Infectious Disease • Transplantation
|
|
Allison Abendroth; Barry Slobedman; Danya Kaplan; David J Gottlieb; Emily Blyth; Gaurav Sutrave; Lauren Stern; Michelle K Yong
|